Saad, R., Costeira, R., Matias Garcia, P. ...
· genetics
· University College London
· biorxiv
Theobromine, a commonly consumed dietary alkaloid derived from cocoa, has been linked to extended lifespan in model organisms and to health benefits in humans. We examined associations between circulating theobromine intake, measured using serum metabolomics, and blood-based epig...
Theobromine, a commonly consumed dietary alkaloid derived from cocoa, has been linked to extended lifespan in model organisms and to health benefits in humans. We examined associations between circulating theobromine intake, measured using serum metabolomics, and blood-based epigenetic markers of biological ageing in two European human population-based cohorts. Serum theobromine levels were significantly associated with reduced epigenetic age acceleration, as measured by GrimAge (p<2e-7) and DNAmTL (p<0.001) in over 500 individuals from the TwinsUK cohort, and both signals replicated in 1,160 individuals from the KORA cohort (p = 7.2e-08 and p = 0.007, respectively). Sensitivity analyses including covariates of other cocoa and coffee metabolites suggest that the effect is specific to theobromine. Our findings indicate that the reported beneficial links between theobromine intake on health and ageing extend to the molecular epigenetic level in humans.
Longevity Relevance Analysis
(5)
Theobromine intake is associated with reduced epigenetic age acceleration in humans. This study explores a dietary compound's potential role in influencing biological aging, which is directly relevant to longevity research.
Kate Hitpass Romero, Taylor J Stevenson, Leon C D Smyth ...
· Journal of neuroinflammation
· Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Auckland, New Zealand.
· pubmed
Efficient clearance of central nervous system (CNS) waste proteins and appropriate immune surveillance is essential for brain health. These processes are facilitated by lymphatic networks present in the meninges that drain cerebrospinal fluid (CSF). Age-related impairments to men...
Efficient clearance of central nervous system (CNS) waste proteins and appropriate immune surveillance is essential for brain health. These processes are facilitated by lymphatic networks present in the meninges that drain cerebrospinal fluid (CSF). Age-related impairments to meningeal lymphatic drainage contribute to CNS waste accumulation and immune dysfunction, yet the underlying mechanisms remain poorly understood. Here, we identify extracellular matrix (ECM) remodeling in the aged dura as a key driver of CSF clearance deficits, demonstrating that peri-lymphatic collagen accumulation disrupts lymphatic function. Exploring immune-derived factors contributing to this ECM remodeling, we identify transforming growth factor beta 1 (TGFβ1) as a major regulator using primary human dural fibroblasts. Using a novel mouse model with constitutively active TGFβ receptor 1 (TGFβR1) signaling in dural fibroblasts, we show that excessive peri-lymphatic collagen deposition impairs meningeal lymphatic drainage and alters meningeal immunity. Mechanistically, we reveal that ECM-associated matrix stiffness disrupts lymphatic junction integrity and impairs lymphangiogenesis in human lymphatic endothelial cells. These findings establish dural immune cell and fibroblast-mediated ECM remodeling as a critical regulator of CSF clearance and highlight it as a potential therapeutic target for restoring brain waste clearance in aging.
Longevity Relevance Analysis
(5)
The paper claims that age-related extracellular matrix remodeling in the dura mater impairs meningeal lymphatic function, contributing to CNS waste accumulation. This research addresses a potential root cause of age-related decline in brain health, focusing on mechanisms that could be targeted for therapeutic intervention in aging.
Kristina Bubb, Julia Etich, Kristina Probst ...
· Mechanistic Target of Rapamycin Complex 1
· Department of Pediatrics and Adolescent Medicine, Experimental Neonatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
· pubmed
Decline of mitochondrial respiratory chain (mtRC) capacity is a hallmark of mitochondrial diseases. Patients with mtRC dysfunction often present reduced skeletal growth as a sign of premature cartilage degeneration and aging, but how metabolic adaptations contribute to this pheno...
Decline of mitochondrial respiratory chain (mtRC) capacity is a hallmark of mitochondrial diseases. Patients with mtRC dysfunction often present reduced skeletal growth as a sign of premature cartilage degeneration and aging, but how metabolic adaptations contribute to this phenotype is poorly understood. Here we show that, in mice with impaired mtRC in cartilage, reductive/reverse TCA cycle segments are activated to produce metabolite-derived amino acids and stimulate biosynthesis processes by mechanistic target of rapamycin complex 1 (mTORC1) activation during a period of massive skeletal growth and biomass production. However, chronic hyperactivation of mTORC1 suppresses autophagy-mediated organelle recycling and disturbs extracellular matrix secretion to trigger chondrocytes death, which is ameliorated by targeting the reductive metabolism. These findings explain how a primarily beneficial metabolic adaptation response required to counterbalance the loss of mtRC function, eventually translates into profound cell death and cartilage tissue degeneration. The knowledge of these dysregulated key nutrient signaling pathways can be used to target skeletal aging in mitochondrial disease.
Longevity Relevance Analysis
(5)
The paper claims that mitochondrial dysfunction leads to metabolic adaptations that initially promote skeletal growth but ultimately result in cartilage degeneration due to mTORC1 hyperactivation. This research is relevant as it addresses the underlying metabolic mechanisms contributing to skeletal aging and offers insights into potential interventions for age-related degeneration.
Chaudhary, R., Cordova, B. A., Hong, M. ...
· immunology
· Department of Medicine, and Case Comprehensive Cancer Center Case Western Reserve University, Cleveland, OH, USA
· biorxiv
Hematopoietic aging is characterized by diminished stem cell regenerative capacity and an increased risk of hematologic dysfunction. We previously identified that the prostaglandin-degrading enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) regulates hematopoietic stem cell ...
Hematopoietic aging is characterized by diminished stem cell regenerative capacity and an increased risk of hematologic dysfunction. We previously identified that the prostaglandin-degrading enzyme 15-hydroxyprostaglandin dehydrogenase (15-PGDH) regulates hematopoietic stem cell activity. Here, we expand on this work and demonstrate that in aged mice, (1) 15-PGDH expression and activity remain conserved in the bone marrow and spleen, suggesting it remains a viable therapeutic target in aging, (2) prolonged PGDH inhibition (PGDHi) significantly increases the frequency and number of phenotypic hematopoietic stem and progenitor cells across multiple compartments, with transcriptional changes indicative of enhanced function, (3) PGDHi-treated bone marrow enhances short-term hematopoietic recovery following transplantation, leading to improved peripheral blood output and accelerated multilineage reconstitution, and (4) PGDHi confers a competitive advantage in primary hematopoietic transplantation while mitigating age-associated myeloid bias in secondary transplants. Notably, these effects occur without perturbing steady-state blood production, suggesting that PGDHi enhances hematopoiesis under regenerative conditions while maintaining homeostasis. Our work identifies PGDHi as a translatable intervention to rejuvenate aged HSCs and mitigate hematopoietic decline.
Longevity Relevance Analysis
(5)
Inhibition of 15-PGDH enhances hematopoietic stem cell function and recovery in aged mice. This research addresses the decline in stem cell regenerative capacity associated with aging, targeting a mechanism that could potentially rejuvenate hematopoietic function and mitigate age-related decline.
Galimberti, M., Levey, D. F., Deak, J. D. ...
· genetic and genomic medicine
· Yale Univ. School of Medicine
· medrxiv
Physical activity (PA) is one of the most fundamental of all traits in the animal kingdom, has pervasive health benefits, and is genetically influenced. Using data from the Million Veteran Program (MVP), we conducted genetic analyses of leisure, work, and home-time PA. For leisur...
Physical activity (PA) is one of the most fundamental of all traits in the animal kingdom, has pervasive health benefits, and is genetically influenced. Using data from the Million Veteran Program (MVP), we conducted genetic analyses of leisure, work, and home-time PA. For leisure, for individuals of European (EUR) ancestry, n=189,812 and SNP-based heritability (h2)=0.083+/-0.005; for African ancestry, n=27,044; h2= 0.034+/-0.017; and for Latin-American ancestry, n=10,263; h2= 0.083+/-0.036. EUR and cross-ancestry meta-analyses with UK Biobank identified 67 and 70 lead variants. Leisure-time PA was genetically distinct from PA at home or work, with the latter two showing less health benefit on pathologies and lifespan. Mendelian randomization analyses showed protective effects of leisure-time PA on cardiovascular and respiratory system diseases, metabolic traits, aging, and other traits, and there was protective role of leisure-time PA against COVID-19 hospitalization ({beta}=-0.067+/-0.016; p-value=2.8x10-5). These findings provide new insights into the biology of PA, showing the causal health benefits of leisure-time PA.
Longevity Relevance Analysis
(5)
Leisure-time physical activity has protective effects on various health outcomes, including cardiovascular diseases and aging-related traits. The paper is relevant as it explores the genetic influences on physical activity and its direct implications for health and longevity, addressing factors that can contribute to lifespan extension.
Kechuan Lin, Xin Luo, Can Du ...
· MicroRNAs
· Department of geriatric, Coronary Circulation Center, Xiangya Hospital of Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan 410008, China; The Third Xiangya Hospital of Central South University, Changsha, Hunan 410008, China.
· pubmed
Vascular aging, marked by endothelial cell (EC) dysfunction and compromised angiogenesis, is a central driver of age-related ischemic diseases. Although lncRNAs have emerged as pivotal regulators of endothelial function, their specific roles in endothelial aging remain enigmatic....
Vascular aging, marked by endothelial cell (EC) dysfunction and compromised angiogenesis, is a central driver of age-related ischemic diseases. Although lncRNAs have emerged as pivotal regulators of endothelial function, their specific roles in endothelial aging remain enigmatic. In this study, we identify the lncRNA ANRIL as a crucial modulator of endothelial dysfunction during aging. By analyzing publicly available lncRNA sequencing datasets comparing young and old ECs, we pinpointed ANRIL and validated its role through a replicative senescence model in human umbilical vein ECs (HUVECs) and FACS sorting of skeletal muscle ECs from aged mice. While ANRIL showed minimal direct effects on angiogenesis, functional assays and transcriptomic analysis revealed its profound impact on the senescence-associated secretory phenotype (SASP). Remarkably, ANRIL regulates the expression of miR146a in ECs, which is transferred to macrophages, where it inhibits VEGF secretion and disrupts endothelial neovascularization. In vivo, ANRIL downregulation in a murine hindlimb ischemia model significantly enhanced neovascularization and restored blood flow, revealing its therapeutic potential for ischemic diseases. These findings position ANRIL as a novel, potent regulator of endothelial senescence, offering new insights into the molecular basis of vascular aging and suggesting ANRIL as a promising therapeutic target to mitigate age-related vascular dysfunction.
Longevity Relevance Analysis
(5)
ANRIL regulates endothelial senescence and angiogenesis through SASP-driven miR146a regulation, highlighting its potential as a therapeutic target for age-related vascular dysfunction. The paper addresses the underlying mechanisms of endothelial aging and suggests a novel approach to mitigate vascular dysfunction, which is directly relevant to longevity research.